GLP-1 receptor agonists were developed to manage type 2 diabetes, but growing clinical evidence indicates they may offer broader benefits for systemic inflammation
This is why its often talked about in the context of muscle growth, fat metabolism, and tissue recovery
The goal is to make sure BPC-157 is the right tool for your situation and that it is administered in a way that maximizes both safety and efficacy
Secondly, an 8-week follow-up duration may not be sufficient to observe long-term metabolic and clinical changes (e.g., the development of other medical co-morbidities)
doi: 10.1172/jci.insight.159863 [DOI] [PMC free article] [PubMed] [Google Scholar] 48.Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW
You leave with the prescription, the schedule, and a written plan covering what to expect in week one